Evidence level: B
导言
2019 年第 72 届世界卫生大会通过 ICD-11,首次将传统医学章(TM1 / Chapter 26)写入 WHO 国际疾病分类。但 ICD-11 TM 章与中日韩三国国内标准(中国 1993/2002/2017/2023《中医病证诊断疗效标准》、《中医临床诊疗术语》、《中医内科常见病诊疗指南》四版;韩国 TKM Standard Korean Medical Terminologies;日本 Kampo 标准用方集)在证候条目、严重度切点、术语映射规则上并不一致。
这一轮要回答的问题是:当一个跨中心、跨国验证的辨证模型在 ICD-11 标准训练、用国家标准测试时,性能损失(漂移)由哪几个独立可分解的成分构成?能不能用三轴归因法在第一时间告诉工程师——是修数据、修模型,还是改标注? 这是 #134 三轴归因法(Device-shift / Diagnosis-criterion-shift / Concept-shift)的跨文化扩展(#145,方法学国际化方向)。
正文
一、ICD-11 TM 章的”国际语言化”承诺与现实落差
Lee 等 (2026, PMID 42793550) 在 Healthcare (Basel) 的范围综述统计了 2016-03 至 2026-03 期间 16,763 条记录,纳入 10 项研究,量化了 TEAM(TCM/TKM/Kampo)在国际健康信息学标准中的可表征性。结果显示一个关键事实:260 个 ICD-11 Chapter 26 证候条目中,仅 1 个在 SNOMED CT 中存在对应编码。换言之,ICD-11 TM 章虽然在国际法律层面被通过,但与生物医学主流术语体系的互操作性几乎为零。OMOP CDM 是唯一被使用的数据模型;HL7 FHIR 交换标准在 TEAM 上”零部署”。
Choi (2020, PMID 32891598) 在 J Integr Med 同期指出,TM 章呈现的 260 条证候”只是 TEAM 临床实践的冰山一角”,必须先做客观化、标准化,再与现代科技嫁接;并提出 PIPE-11 临床决策支持系统作为补强 ICD-11 落地的工具。这说明 ICD-11 TM 章被设计为”最小公分母”——可让 WHO 成员国共同投票通过,但跨标准映射和互操作必须由后续标准化工作承担。
二、LTA:把”主观辨证”转成”可计算分值”
Ho 等 (2022a, PMID 35994848) 在 Phytomedicine 提出基于潜在树分析(Latent Tree Analysis, LTA)的客观化辨证方法,把专家共识转译为”症状-证候”互信息评分+累积信息覆盖率;每条症状赋分,加和超过阈值即诊断为该证候。LTA 把传统辨证中”三个医师三个结果”的临床困境,转为可重复的数值判定。
该团队 2022b (PMID 36038888, Chinese Medicine) 在功能性消化不良(FD)上做了实证:从香港 250 例 + 湖南 150 例的横断面数据中导出 8 条证候判定规则。结果:
– 香港最常见:寒热错杂(59.8%)
– 湖南最常见:脾胃湿热(77.1%)
– 同一疾病、同一种语言、同一种辨证体系、不同地理位置 → 证候分布可以天差地别。
这意味着 LTA 即使在”国家标准”内部,也已经出现”地理版本漂移”;当 LTA 模型在 ICD-11 与国家标准之间迁移时,漂移会更严重。
三、三轴归因框架的跨文化扩展(DDC × DCC × LTA)
把 #134 三轴诊断框架 DDC(Device-shift / Diagnosis-criterion-shift / Concept-shift)从单中心跨设备场景扩展到跨文化场景:
轴 1 — 设备漂移 DDC.Device:HRI 谐波向量在不同品牌脉象仪的 SDPTG b/a 比、ComBat 校正残留、固件版本差异。P3-EXP-040 已建立锚点回打分的校正流程。
轴 2 — 标准漂移 DDC.Diagnosis(本轮主线):把”辨证标准”由单一中国 1993/2002/2017/2023 四版扩展为”中国 4 版 × ICD-11 TM 章 1 版 × 韩国 1 版 × 日本 Kampo 1 版” = 至少 7 个诊断标签维度。
– 条目层:每个证候在某版中的”主症 + 次症 + 舌脉”组合不一致 → 互转映射矩阵(参 P3-EXP-036 草案)。
– 权重层:同一条目在不同版本的”主症权重 vs 次症权重”不一致。
– 切点层:轻/中/重切点随能量代谢指标(2023 版)、舌象(1993 版)、脉象(Kampo)各异。
轴 3 — 概念漂移 DDC.Concept:证候背后的病机定义不同。例如”脾虚”在 ICD-11 TM 章强调消化系统功能减退,在中国 2002 版强调气化不足,在 2023 版强调线粒体能量代谢。同一”脾虚”标签背后是不同的病理生理学假说 → 这是不可还原为标签差异的”概念偏移”。
四、把 LTA 当归因工具:得分残差 = 三轴贡献分解
LTA 在每个证候上的”症状得分”实际上编码了”该症状对证候判定的互信息权重”。当跨标准版迁移时,可设计三轴分解:
残差 R_model(标准 B | 标准 A) = α·DDC.Device + β·DDC.Diagnosis + γ·DDC.Concept + ε
- 阶段 1:仿真注入已知偏移,分别测三轴单独贡献
- 阶段 2:多中心盲法验证失败样本,三轴 SHAP 归因
- 阶段 3:反事实干预(仅修设备 / 仅修标签 / 仅修概念)对比残差下降比例 → 得 α/β/γ 实测分解
五、跨文化场景的额外挑战:本地化 ICD-11 配套落地差距
Lee 2026 (PMID 42793550) 提示:OMOP CDM 在韩国 TKM 已被部署 (Park 2026, BMC Med Inform Decis Mak),日本 Kampo 因”无独立映射研究”在范围综述中”零数据”。这意味着即使方法学成熟,跨文化外部验证在某些地区连基线数据都没有。本轮三轴归因法必须允许”α+β+γ < 1″(残差不可解释)作为有效结果,触发”数据补强优先于模型修正”。
证据与局限
- 证据层级 B(间接证据链):ICD-11 TM 章可表征性、跨地区证候分布、互转映射公式草案 = 三段已发表方法学,连接为间接链;跨中心、跨国 ICD-11 配套标准版与四套国家标准共同标注同一 HRI 波形 → 跨标准版归因的直接验证尚无。
- 证据边界:PubMed 直接命中 “cross-cultural ICD-11 TM chapter kappa consistency” = 0;本轮三轴分解系数 α/β/γ 仅在 P3-EXP-048 阶段 1 仿真可估计;HRI 谐波向量依赖 P3-EXP-040 ComBat 校正链;样本以心气虚为限(其他证型条目异质性大,需 P3-EXP-036/#116 扩展)。
- 风险 medium:跨国家跨中心 IRB 协调周期长;OMOP CDM 部署程度国别差距大;不可外推至儿童/孕产/重症。
- 合规:本文不构成医疗建议;证候判定须由执业中医师完成;跨文化映射条目需经多国监管/学术机构联合审核。
相关阅读
- meta-learning-cross-zang-transfer-blind-validation-failure-attribution.md(DDC 三轴基础框架)
- tcm-syndrome-meta-learning-zero-shot-2025-future-version-adaptation.md(合成扰动外推方法)
- tcm-syndrome-diagnostic-criteria-version-mapping-hri-implementation.md(中国 1993/2002/2017/2023 四版互转映射草案)
- tcm-syndrome-meta-learning-standard-version-adaptation.md(标准版本作为元特征)
- modified-combat-affine-calibration-east-asian-ppg-multi-center-multi-device-anchor-rescore.md(轴 1 设备漂移校正)
引用
- Lee S, Woo Y, Lee S. Representing Traditional East Asian Medicine in International Health Informatics Standards: A Scoping Review. Healthcare (Basel). 2026;14(18):3011. PMID: 42793550. DOI: 10.3390/healthcare14183011
- Ho L, Zhang NL, Xu Y, et al. Latent tree analysis for the identification and differentiation of evidence-based Traditional Chinese Medicine diagnostic patterns: A primer for clinicians. Phytomedicine. 2022;106:154392. PMID: 35994848. DOI: 10.1016/j.phymed.2022.154392
- Choi SH. A digital application for implementing the ICD-11 traditional medicine chapter. J Integr Med. 2020;18(6):455-458. PMID: 32891598. DOI: 10.1016/j.joim.2020.08.003
- Ho L, Xu Y, Zhang NL, et al. Quantification of prevalence, clinical characteristics, co-existence, and geographic variations of traditional Chinese medicine diagnostic patterns via latent tree analysis-based differentiation rules among functional dyspepsia patients. Chin Med. 2022;17:101. PMID: 36038888. DOI: 10.1186/s13020-022-00656-x
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
ICD-11 Traditional Medicine Chapter vs National Standards: A Cross-Cultural External Drift Attribution Framework (Three-Axis DDC × DCC × LTA)
Evidence level: B
Introduction
The 72nd World Health Assembly adopted ICD-11 in 2019, marking the first inclusion of the Traditional Medicine chapter (TM1 / Chapter 26) in the WHO International Classification of Diseases. However, ICD-11 TM does not align with domestic standards in China (1993/2002/2017/2023 Standard for Diagnosis and Efficacy of Diseases in Traditional Chinese Medicine, Clinical Diagnostic Terminology of TCM, Guidelines for Diagnosis and Treatment of Common Internal Diseases in TCM (4th ed.); Korea’s TKM Standard Korean Medical Terminologies; Japan’s Kampo Standard Prescriptions) regarding syndrome entries, severity thresholds, and terminology mapping rules.
The question this round addresses is: When a cross-center, cross-national diagnostic model trained on ICD-11 standards is tested against national standards, what independent, decomposable components constitute the performance loss (drift)? Can a three-axis attribution method immediately inform engineers whether to revise data, the model, or annotations? This represents a cross-cultural extension of #134 Three-Axis Attribution (Device-shift / Diagnosis-criterion-shift / Concept-shift) toward methodological internationalization (#145).
Main Text
I. The “International Language” Promise and Reality Gap of ICD-11 TM
Lee et al. (2026, PMID 42793550) conducted a scoping review in Healthcare (Basel) covering records from March 2016 to March 2026, analyzing 16,763 records across 10 studies to quantify the representability of TEAM (TCM/TKM/Kampo) within international health informatics standards. A key finding emerged: Of the 260 syndrome entries in ICD-11 Chapter 26, only one has a corresponding code in SNOMED CT. In other words, despite ICD-11 TM’s passage at the international legal level, interoperability with mainstream biomedical terminology is virtually zero. OMOP CDM remains the sole deployed data model; HL7 FHIR exchange standards show “zero deployment” for TEAM.
Choi (2020, PMID 32891598) noted in J Integr Med that the 260 syndromes presented in TM represent merely “the tip of the iceberg” of TEAM clinical practice, necessitating objectification and standardization before integration with modern technology. The PIPE-11 clinical decision support system is proposed as a tool to bolster ICD-11 implementation. This indicates that ICD-11 TM is designed as a “lowest common denominator”—enabling joint voting by WHO member states—while cross-standard mapping and interoperability must be addressed through subsequent standardization efforts.
II. LTA: Converting “Subjective Diagnosis” into “Computable Scores”
Ho et al. (2022a, PMID 35994848) proposed an objectified diagnostic method based on Latent Tree Analysis (LTA) in Phytomedicine, translating expert consensus into “symptom-syndrome” mutual information scores plus cumulative information coverage. Each symptom is assigned a score; diagnosis occurs when the sum exceeds a threshold. LTA transforms the clinical dilemma of “three doctors, three results” in traditional diagnosis into a repeatable numerical judgment.
In a validation study on functional dyspepsia (FD), the team (2022b, PMID 36038888, Chinese Medicine) derived eight syndrome judgment rules from cross-sectional data comprising 250 cases in Hong Kong and 150 in Hunan. Results showed:
– Most common in Hong Kong: Cold-Heat Complexity (59.8%)
– Most common in Hunan: Spleen-Stomach Damp-Heat (77.1%)
– Same disease, same language, same diagnostic system, different geographic locations → Syndrome distribution can vary drastically.
This implies that even within “national standards,” LTA exhibits “geographic version drift”; when LTA models migrate between ICD-11 and national standards, the drift becomes more severe.
III. Cross-Cultural Extension of the Three-Axis Attribution Framework (DDC × DCC × LTA)
Extending the #134 Three-Axis Diagnostic Framework DDC (Device-shift / Diagnosis-criterion-shift / Concept-shift) from single-center cross-device scenarios to cross-cultural contexts:
Axis 1 — Device Drift DDC.Device: Harmonic vectors in HRI vary across brands of pulse-photoplethysmography (PPG) devices due to SDPTG b/a ratios, ComBat calibration residuals, and firmware version differences. P3-EXP-040 has established an anchor re-scoring calibration workflow.
Axis 2 — Standard Drift DDC.Diagnosis (Main focus of this round): Expands “diagnostic criteria” from the single set of four Chinese versions (1993/2002/2017/2023) to “Chinese 4 versions × ICD-11 TM 1 version × Korean 1 version × Japanese Kampo 1 version” = at least 7 diagnostic label dimensions.
– Entry level: Inconsistent combinations of “main symptoms + secondary symptoms + tongue/pulse” for each syndrome across versions → requires an inter-version mapping matrix (see P3-EXP-036 draft).
– Weight level: Inconsistent weighting of “main symptoms vs. secondary symptoms” for the same entry across versions.
– Threshold level: Light/Moderate/Severe thresholds vary by energy metabolism indicators (2023 version), tongue appearance (1993 version), or pulse characteristics (Kampo).
Axis 3 — Concept Drift DDC.Concept: Differing definitions of pathogenesis underlying syndromes. For example, “Spleen Deficiency” in ICD-11 TM emphasizes reduced digestive function; in the Chinese 2002 version, it emphasizes Qi transformation deficiency; in the 2023 version, it emphasizes mitochondrial energy metabolism. The same “Spleen Deficiency” label embodies different pathophysiological hypotheses → this is a “conceptual shift” irreducible to label differences.
IV. Applying LTA as an Attribution Tool: Score Residuals = Three-Axis Contribution Decomposition
The “symptom score” for each syndrome in LTA encodes the “mutual information weight of that symptom for syndrome diagnosis.” When migrating across standard versions, a three-axis decomposition can be designed:
Residual R_model(Standard B | Standard A) = α·DDC.Device + β·DDC.Diagnosis + γ·DDC.Concept + ε
- Stage 1: Simulate known shifts to measure individual contributions of the three axes.
- Stage 2: Validate failed samples via multi-center blind testing using three-axis SHAP attribution.
- Stage 3: Compare residual reduction ratios via counterfactual interventions (fixing only device / only labels / only concepts) to obtain empirical α/β/γ decomposition.
V. Additional Challenges in Cross-Cultural Scenarios: Localized ICD-11 Implementation Gaps
Lee (2026, PMID 42793550) indicates that OMOP CDM is deployed in Korea’s TKM (Park 2026, BMC Med Inform Decis Mak), while Japan’s Kampo shows “zero data” in the scoping review due to “lack of independent mapping studies.” This means that even with mature methodologies, cross-cultural external validation lacks baseline data in certain regions. The three-axis attribution method presented here must allow for “α + β + γ < 1” (unexplained residuals) as a valid result, triggering a priority of “data reinforcement over model correction.”
Evidence and Limitations
- Evidence Level B (Indirect Evidence Chain): Representability of ICD-11 TM, cross-regional syndrome distribution, and inter-version mapping formula drafts constitute three published methodological links forming an indirect chain; direct validation of cross-standard attribution via multi-center, cross-national ICD-11 standard versions jointly annotating the same HRI waveform remains absent.
- Evidence Boundaries: PubMed direct hits for “cross-cultural ICD-11 TM chapter kappa consistency” = 0; the three-axis decomposition coefficients α/β/γ in this round are estimable only via Stage 1 simulation in P3-EXP-048; HRI harmonic vectors rely on the P3-EXP-040 ComBat calibration chain; samples are limited to Heart Qi Deficiency (high heterogeneity in other syndrome entries, requiring extension via P3-EXP-036/#116).
- Risk Medium: Cross-national/cross-center IRB coordination cycles are long; OMOP CDM deployment varies significantly by country; results cannot be extrapolated to children/pregnancy/critical care.
- Compliance: This article does not constitute medical advice; syndrome diagnosis must be performed by licensed TCM practitioners; cross-cultural mapping entries require joint review by multiple regulatory/academic institutions.
Related Reading
- meta-learning-cross-zang-transfer-blind-validation-failure-attribution.md (Basic DDC Three-Axis Framework)
- tcm-syndrome-meta-learning-zero-shot-2025-future-version-adaptation.md (Synthetic Perturbation Extrapolation)
- tcm-syndrome-diagnostic-criteria-version-mapping-hri-implementation.md (Draft Inter-version Mapping for Chinese 1993/2002/2017/2023 Versions)
- tcm-syndrome-meta-learning-standard-version-adaptation.md (Standard Versions as Meta-features)
- modified-combat-affine-calibration-east-asian-ppg-multi-center-multi-device-anchor-rescore.md (Axis 1 Device Drift Correction)
References
- Lee S, Woo Y, Lee S. Representing Traditional East Asian Medicine in International Health Informatics Standards: A Scoping Review. Healthcare (Basel). 2026;14(18):3011. PMID: 42793550. DOI: 10.3390/healthcare14183011
- Ho L, Zhang NL, Xu Y, et al. Latent tree analysis for the identification and differentiation of evidence-based Traditional Chinese Medicine diagnostic patterns: A primer for clinicians. Phytomedicine. 2022;106:154392. PMID: 35994848. DOI: 10.1016/j.phymed.2022.154392
- Choi SH. A digital application for implementing the ICD-11 traditional medicine chapter. J Integr Med. 2020;18(6):455-458. PMID: 32891598. DOI: 10.1016/j.joim.2020.08.003
- Ho L, Xu Y, Zhang NL, et al. Quantification of prevalence, clinical characteristics, co-existence, and geographic variations of traditional Chinese medicine diagnostic patterns via latent tree analysis-based differentiation rules among functional dyspepsia patients. Chin Med. 2022;17:101. PMID: 36038888. DOI: 10.1186/s13020-022-00656-x
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply